Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 2 | CD44A | IM / AR |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | UNK | U8508AA | IM / AR |
The meningitis vaccine dosing schedule is as follows:, per ACIP guidelines. -Bexsero THREE dose selection: Day 0 , 1-2 months and 6 months -MenQuadfi TWO dose selection : Day 0, 2 months This patient administered first doses on 06/03/2025 and 2nd doses were administered on 07/17/2025 , 12 days prior to recommendation per ACIP guidelines. Pharmacist reached out to MDO, pending as he had to lvm- still pending contact HCP for direction